Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-026273

President and CEO sold 4,481 shares at $15.00 ($67,215)

  • President and CEO acquired 4,481 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-26 Exercise or conversion : show line 1 in the form +4,481 $0.95 $4,235 8,726 D
2017-06-26 Sale : show line 2 in the form +4,481 $15.00 $67,215 4,245 D
Open-market sales · 4,481 sh · avg $15.00 · $67,215

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-06-26 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −4,481 63,291 D
Loading xslF345X03/doc1.xml…